Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome - PubMed (original) (raw)

Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome

Jorge Busciglio et al. Neuron. 2002.

Free article

Abstract

Most Down's syndrome (DS) patients develop Alzheimer's disease (AD) neuropathology. Astrocyte and neuronal cultures derived from fetal DS brain show alterations in the processing of amyloid beta precursor protein (AbetaPP), including increased levels of AbetaPP and C99, reduced levels of secreted AbetaPP (AbetaPPs) and C83, and intracellular accumulation of insoluble Abeta42. This pattern of AbetaPP processing is recapitulated in normal astrocytes by inhibition of mitochondrial metabolism, consistent with impaired mitochondrial function in DS astrocytes. Intracellular Abeta42 and reduced AbetaPPs are also detected in DS and AD brains. The survival of DS neurons is markedly increased by recombinant or astrocyte-produced AbetaPPs, suggesting that AbetaPPs may be a neuronal survival factor. Thus, mitochondrial dysfunction in DS may lead to intracellular deposition of Abeta42, reduced levels of AbetaPPs, and a chronic state of increased neuronal vulnerability.

PubMed Disclaimer

Cited by

ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J. Helguera P, et al. J Neurosci. 2005 Mar 2;25(9):2295-303. doi: 10.1523/JNEUROSCI.5107-04.2005. J Neurosci. 2005. PMID: 15745955 Free PMC article.
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Oakley H, et al. J Neurosci. 2006 Oct 4;26(40):10129-40. doi: 10.1523/JNEUROSCI.1202-06.2006. J Neurosci. 2006. PMID: 17021169 Free PMC article.
Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.
Yang X, Yang Y, Wu J, Zhu J. Yang X, et al. J Mol Neurosci. 2007;33(2):180-8. doi: 10.1007/s12031-007-0063-y. J Mol Neurosci. 2007. PMID: 17917077
Mitochondrial fragmentation and network architecture in degenerative diseases.
Shah SI, Paine JG, Perez C, Ullah G. Shah SI, et al. PLoS One. 2019 Sep 26;14(9):e0223014. doi: 10.1371/journal.pone.0223014. eCollection 2019. PLoS One. 2019. PMID: 31557225 Free PMC article.
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
Butterfield DA, Reed T, Newman SF, Sultana R. Butterfield DA, et al. Free Radic Biol Med. 2007 Sep 1;43(5):658-77. doi: 10.1016/j.freeradbiomed.2007.05.037. Epub 2007 Jun 13. Free Radic Biol Med. 2007. PMID: 17664130 Free PMC article. Review.

Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome - PubMed (original) (raw)